The role of endogenous opioid systems in neuroendocrine regulation.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001921:Brain / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003866:Depressive Disorder / Q000097:blood*; D004723:Endorphins / Q000378:metabolism / Q000502:physiology*; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D010830:Physostigmine; D010902:Pituitary Gland / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000502:physiology; D013972:Thyrotropin / Q000378:metabolism; D001615:beta-Endorphin
D004723:Endorphins; D006065:Gonadotropins, Pituitary; D018377:Neurotransmitter Agents; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D003346:Corticotropin-Releasing Hormone; D010830:Physostigmine